Ming Yuan - Concepedia

Author

Ming Yuan

Queen Mary University of London ORCID

Also Known As

M Yuan, M. Yuan, Mao-Sha Yuan, Maosha Yuan, Mengyuan Yuan, Ming Wu Yuan, Ming Yuan

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Queen Mary University of London Zhengzhou University Cancer Research UK William Harvey Research Institute Peking University Sixth Hospital

About

Ming Yuan is an author at Queen Mary University of London specializing in medicine, engineering, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	548
2	Engineering	5	5	178
3	Applied Physics	2	2	72
4	Social Sciences	1	1	18
5	Biomedical Engineering	1	1	37

Ming Yuan

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Yes-associated protein (YAP) functions as a tumor suppressor in breast Ming Yuan, V Tomlinson, Romain Lara, Cell Death and Differentiation Protein FunctionSignal TransductionBreast OncologyMedicineYes-associated Protein	2008	332
Efficiently Editing the Vaccinia Virus Genome by Using the CRISPR-Cas9 System Ming Yuan, Wensheng Zhang, Jun Wang, Journal of Virology	2015	106
A Novel Therapeutic Regimen to Eradicate Established Solid Tumors with an Effective Induction of Tumor-Specific Immunity James R. Tysome, Xiaozhu Li, Shengdian Wang, Clinical Cancer Research	2012	67
Lister strain vaccinia virus, a potential therapeutic vector targeting hypoxic tumours Crispin T. Hiley, Ming Yuan, Nicholas R. Lemoine, Gene Therapy VaccinationPathogenesisViral PathogenesisVirologyPotential Therapeutic Vector	2009	65
Melt-stretched poly(vinylidene fluoride)/zinc oxide nanocomposite films with enhanced piezoelectricity by stress concentrations in piezoelectric domains for wearable electronics Ming Yuan, Ruixue Ma, Qiuyang Ye, Chemical Engineering Journal Materials ScienceEngineeringEnhanced PiezoelectricityNanomaterialsPiezoelectric Nanogenerators	2022	60
A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9 Ming Yuan, Xuefei Gao, Louisa S. Chard, Molecular Therapy — Methods & Clinical Development EngineeringSynthetic VirologyImmunologyCre-loxp SystemMarker Gene	2015	56
A new oncolytic <i>V</i> <i>accinia</i> <i>virus</i> augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery Jahangir Ahmed, Louisa S. Chard, Ming Yuan, Journal for ImmunoTherapy of Cancer	2020	53
c-Abl phosphorylation of ΔNp63α is critical for cell viability Ming Yuan, Phuong Luong, Chris Hudson, Cell Death and Disease	2010	52
BDNF-GSK-3β-β-Catenin Pathway in the mPFC Is Involved in Antidepressant-Like Effects of<i>Morinda officinalis</i>Oligosaccharides in Rats Lingzhi Xu, Defeng Xu, Ying Han, The International Journal of Neuropsychopharmacology	2016	51
Virus-Associated RNA I–Deleted Adenovirus, a Potential Oncolytic Agent Targeting EBV-Associated Tumors Yaohe Wang, Shao‐An Xue, Gunnel Halldén, Cancer Research	2005	41

Page 1